GLP-1 agonists like Semaglutide help to control your blood sugar, but people taking them also tend to lose weight
Liraglutide (Saxenda for obesity, Victoza for diabetes) is administered as a once-daily subcutaneous injection
This research was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2025R73), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Transcutol-HP (diethylene glycol monoethyl ether), at 6% in a gel formulation, enhanced skin absorption 3.7-fold, in comparison with CBD in a propylene glycol-hydroxyethyl cellulose gel [222]
The American Academy of Dermatology notes that visible facial changes during GLP-1 treatment may involve changes in facial fat, muscle, and collagen, particularly when weight is lost rapidly